Dendritic enriched secreted lymphocyte activation molecule

Details Dendritic enriched secreted lymphocyte activation molecule Dendritic enriched secreted lymphocyte activation molecule

2006-03-14

2006-03-14

Kunz, Gary (Department: 1647)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S387100, C530S387700, C530S388100, C530S388150, C430S069000, C430S320000, C536S023500

Reexamination Certificate

active

07012134

ABSTRACT:
The present invention relates to a novel human protein called Dendritic Enriched Secreted Lymphocyte Activation Molecule, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.

REFERENCES:
patent: 5576423 (1996-11-01), Aversa et al.
patent: 94/01548 (1994-01-01), None
patent: 99/40184 (1999-08-01), None
patent: 00/18800 (2000-04-01), None
patent: 01/011046 (2001-02-01), None
patent: 01/046260 (2001-12-01), None
U.S. patent application Ser. No. 09/912,292, Rosen et al.
U.S. patent application Ser. No. 09/912,293, Rosen et al.
Cocks et al., “A novel receptor involved in T-cell activation”, Nature 376:260-263 (1995).
Ferrante et al. “Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis”, J. Immunol. 160:1514-1521 (1998).
Kingsbury et al. “Cloning, expression, and function of BLAME, a novel member of the CD2 family” J. Immunol. 166:5675-5680 (2001).
Punnonen et al. “Soluble and membrane-bound forms of signaling lymphocytic activation molecules (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes” J. Exp. Med. 185(6):993-1004 (1997).
GenBank Accession No. N62522, Hiller et al. (Mar. 1, 1996).
GenBank Accession No. AF144235, Zhang et al., (Jun. 1, 1999).
GenBank Accession No. AA627522, Strausberg et al. (Oct. 31, 1997).
GenBank Accession No. AA320408, Adams et al. (Apr. 19, 1997).
GenBank Accession No. R11635, Hillier et al., (Apr. 11, 1995).
GenBank Accession No. AA379112, Adams et al. (Apr. 21, 1997).
GenBank Accession No. R09841, Hiller et al. (Apr. 6, 1995).
GenBank Accession No. Z20320 (Feb. 7, 1995).
GenBank Accession No. N79421, Hillier et al. (Apr. 2, 1996).
GenBank Accession No. D45800, Itoh et al. (Feb. 20, 1995).
GenBank Accession No. AA917335, Strausberg et al. (Jun. 24, 1998).
GenBank Accession No. AI094818, Strausberg et al., (Oct. 1, 1998).
GenBank Accession No. G22227, Hudson et al. (May 31, 1996).
GenBank Accession No. NP_064510, Kingsbury et al., (Sep. 6, 2003).
GenBank Accession No. NM_020125, Kingsbury et al., (Sep. 6, 2003).
Genseq Accession No. Q76829, Gross et al. (1994).
Database Genbank Nucleotide (P.R. China), Accession No. AF4146761, “Novel human cell membrane protein” (Zhang et al.), May 4, 2000.
International Search Report, Application No. PCT/US02/03227, mailed Oct. 15, 2003.

Affiliated with

Also associated with

Rating

Dendritic enriched secreted lymphocyte activation molecule does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dendritic enriched secreted lymphocyte activation molecule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dendritic enriched secreted lymphocyte activation molecule will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3581570